TATACHEM - Fundamental Analysis: Financial Health & Valuation
Last Updated Time : 20 Dec 25, 11:16 pm
Back to Fundamental ListFundamental Rating: 3.1
| Stock Code | TATACHEM | Market Cap | 19,438 Cr. | Current Price | 763 ₹ | High / Low | 1,107 ₹ |
| Stock P/E | 29.7 | Book Value | 739 ₹ | Dividend Yield | 1.47 % | ROCE | 3.67 % |
| ROE | 2.81 % | Face Value | 10.0 ₹ | DMA 50 | 827 ₹ | DMA 200 | 899 ₹ |
| Chg in FII Hold | 0.88 % | Chg in DII Hold | -0.44 % | PAT Qtr | 178 Cr. | PAT Prev Qtr | 307 Cr. |
| RSI | 25.1 | MACD | -25.9 | Volume | 2,39,933 | Avg Vol 1Wk | 2,60,875 |
| Low price | 745 ₹ | High price | 1,107 ₹ | PEG Ratio | -2.43 | Debt to equity | 0.11 |
| 52w Index | 4.94 % | Qtr Profit Var | 79.8 % | EPS | 26.4 ₹ | Industry PE | 20.0 |
📊 Core Financials: Tata Chemicals shows weak return metrics with ROCE (3.67%) and ROE (2.81%), reflecting poor capital efficiency. Debt-to-equity is low at 0.11, ensuring financial stability. Quarterly PAT declined sharply to 178 Cr. from 307 Cr., highlighting margin pressure. EPS of 26.4 ₹ supports profitability but earnings trend is weakening.
💹 Valuation Indicators: Current P/E of 29.7 is above industry average (20.0), suggesting premium valuation despite weak returns. Book value of 739 ₹ implies a P/B ratio of ~1.03, which is fair. PEG ratio of -2.43 highlights negative growth expectations. Intrinsic value appears lower than CMP, limiting margin of safety.
🏭 Business Model & Competitive Advantage: Tata Chemicals operates in chemicals, specialty products, and consumer-facing businesses. Its competitive advantage lies in brand strength, diversified portfolio, and global presence. However, profitability challenges and weak return ratios reduce overall health.
📈 Entry Zone Recommendation: Current price (763 ₹) is below DMA 50 (827 ₹) and DMA 200 (899 ₹), signaling weak technical momentum. RSI at 25.1 indicates oversold conditions, suggesting possible rebound. Entry zone recommended between 740–770 ₹ for accumulation. Long-term holding is favorable only if earnings recovery materializes.
Positive
- ✅ Low debt-to-equity (0.11) ensures financial stability.
- ✅ Strong brand presence with diversified product portfolio.
- ✅ FII holdings increased (+0.88%), showing foreign investor confidence.
Limitation
- ⚠️ Weak ROCE (3.67%) and ROE (2.81%) reflect poor capital efficiency.
- ⚠️ Quarterly PAT decline (-42%) highlights margin pressure.
- ⚠️ PEG ratio (-2.43) indicates negative growth expectations.
Company Negative News
- 📉 Profitability dropped from 307 Cr. to 178 Cr. in the latest quarter.
- 📉 DII holdings decreased (-0.44%), showing reduced domestic institutional support.
Company Positive News
- 📢 FII holdings increased (+0.88%), reflecting foreign investor support.
- 📢 Strong legacy brand in chemicals and consumer products.
Industry
- ⚗️ Chemical sector benefits from industrial demand and specialty product growth.
- ⚗️ Industry P/E at 20.0 suggests moderate valuations, making Tata Chemicals relatively expensive.
Conclusion
🔎 Tata Chemicals demonstrates financial stability with low debt and strong brand presence, but weak return ratios and declining profitability limit margin of safety. Valuations are stretched relative to industry peers. Best suited for cautious investors seeking exposure to chemicals, with entry near 740–770 ₹. Long-term holding depends on earnings recovery and margin improvement.
Would you like me to extend this into a peer benchmarking overlay comparing Tata Chemicals with peers like UPL, Deepak Nitrite, and Aarti Industries, or a sector rotation basket scan to identify diversified opportunities in chemicals and specialty materials?
Back to Fundamental ListNIFTY 50 - Today Top Fundamental Picks Stock Picks
NEXT 50 - Today Top Fundamental Picks Stock Picks
MIDCAP - Today Top Fundamental Picks Stock Picks
SMALLCAP - Today Top Fundamental Picks Stock Picks